产品封面图

MiF-6 [Mutatect]

收藏
  • 询价
  • 2025年11月22日
    avatar
    ATCC细胞库
    15 年金牌会员

  • 企业认证

    • 相关产品推荐更多 >

    万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 物种来源：

      小鼠

    • 是否是肿瘤细胞：

      0

    • 细胞形态：

      成纤维样

    • 运输方式：

      冻存运输

    • 生长状态：

      贴壁生长

    • 相关疾病：

      纤维肉瘤

    • ATCC Number：

      CRL-2802™

    • 品系：

      C57BL/10

    • 库存：

      大量

    Designations: MiF-6 [Mutatect]
    Depositors:  HC Birnboim
    Biosafety Level: 2 [Cells contain SV-40 and CMV viral DNA sequences ]
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Mus musculus
    Morphology: fibroblast
    Source: Disease: fibrosarcoma
    Strain: C57BL/10
    Cellular Products: mouse siRNA formaldehyde dehydrogenase (FDH)
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Isolation: Isolation date: 2003
    Applications: tumor model
    Tumorigenic: Yes
    Gender: male
    Comments: The Mutatect mouse tumor model is a series of cell lines (eight are available from ATCC ) derived from a murine fibrosarcoma that can grow in culture as well as form subcutaneous tumors in syngeneic C57BL/6 mice. MiF-6 (ATCC CRL-2802 ) and M-7 (ATCC CRL-2804 ) are derivatives of MC-TGS17-51 (ATCC CRL-2799 ). M7 cells were constructed by transfection of MC-TGS17-51 cells with the pCR3.1 vector alone. The vector contains cytomegalovirus (CMV) and SV40 viral sequences and the neomycin resistance gene. M7 cells are used as a control for MiF-6. MiF-6 cells were constructed by transfection of MC-TGS17-51 cells with pRNAi-5 ligated to pCR3.1 to produce a construct expressing mouse double stranded short-interfering ribonucleic acid (siRNA) formaldehyde dehydrogenase (FDH) mRNA. The pRNAi-5 construct targeted the sequence from -18 to +4 of the mRNA, including the start codon. M7 and MiF-6 cells are 6-thioguanine sensitive, neomycin (G418) resistant, hypoxanthine phosphoribosyl transferase positive (HPRT+) and will grow in HAT selection medium. The Mutatect cell lines can be used in vitro/in vivo for the detection of deletion mutations of the hypoxanthine phosphoribosyl transferase (HPRT) gene. They are also useful for the study of inflammatory infiltration of solid tumors.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
      An inoculum of 2 X 10(3) to 6 X 10(3) viable cells/cm2 is recommended.
    6. Incubate cultures at 37�C.

    Interval: Maintain cultures at a cell concentration between 5 X 10(3) and 3 X 10(5) cells/cm2
    Subcultivation Ratio: A subcultivation of 1:4 to 1:6 is recommended
    Medium Renewal: Two to three times weekly
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Doubling Time: 22 hours
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
    recommended serum:ATCC 30-2020
    parental cell line:ATCC CRL-2799
    References: 89373: Haqqani AS, et al. The role of a formaldehyde dehydrogenase-glutathione pathway in protein S-nitrosation in mammalian cells. Nitric Oxide 9: 172-181, 2003. PubMed: 14732341

    风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验

    • 基于多重免疫荧光 (mIF) 技术的空间表型特征用以开发新一代生物标志物

      越来越多的研究表明，基于多重免疫荧光（mIF）技术的空间表型特征正在用以开发新一代生物标志物，它使用多重抗体面板在完整组织样本中通过所处环境中的功能和状态来描述肿瘤和免疫细胞的特征。不同的细胞密度模式和相互作用构成的细胞间肿瘤微环境中（TME）已被证明可以对疾病结果和免疫治疗反应高度预测。 在《空间表型特征：表征实体肿瘤和预测免疫治疗反应的新型生物标志物》白皮书中介绍了基于 mIF 的空间表型特征作为新一代生物标志物发现的案例，意义和价值。 目前，只有少数经 FDA 批准

    • 人巨噬细胞移动抑制因子(MIF)ELISA试剂盒 说明书

        上海西唐生物科技有限公司   021-55229872,  65333639   www.westang.com 人巨噬细胞移动抑制因子 ( MIF )ELISA 试剂盒   ( 用于血清、血浆、细胞培养上清液和其它生物体液内 )   原理 本实验采用双抗体夹心  ABC-ELISA 法。用抗人   MIF   单抗包被于酶标板上，标准品和样品中的   MIF与单抗结合，加入生物素化的抗人 MIF

    • 小鼠巨噬细胞移动抑制因子(MIF)ELISA试剂盒 说明书

        上海西唐生物科技有限公司   021-55229872,  65333639   www.westang.com 小鼠巨噬细胞移动抑制因子 ( MIF )ELISA 试剂盒   ( 用于血清、血浆、细胞培养上清液和其它生物体液内 )   原理 本实验采用双抗体夹心  ABC-ELISA 法。用抗小鼠   MIF   单抗包被于酶标板上，标准品和样品中的   MIF与单抗结合，加入生物素化的抗小鼠

    查看更多相关实验 >
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    Or De
    询价
    ATCC细胞库
    2025年11月03日询价
    ATCC原装细胞，ATCC代理，ATCC中国,ATCC菌株厂家,ATCC厂家，ATCC代理厂家，细胞ATCC感受,ATCC
    询价
    吉奥蓝图（广东）生命科学技术中心
    2025年08月28日询价
    ATCC
    询价
    北京中源合聚生物科技有限公司
    2025年11月17日询价
    HCCLM3细胞系、HCCLM3细胞株、HCCLM3细胞
    ￥1400
    上海盖宁生物科技有限公司
    2025年12月24日询价
    大鼠骨髓瘤细胞
    询价
    上海康朗生物科技有限公司
    2025年07月15日询价
    MiF-6 [Mutatect]
    询价